{"mainPropery":{"diseaseId":10485,"diseaseName":"Morphea","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/10485/morphea","synonyms":[],"synonyms-with-source":[],"identifiers":[{"identifierType":"UMLS","identifierId":"C1527383"},{"identifierType":"MeSH","identifierId":"D012594"}]},"diseaseCategories":[{"diseaseTypeId":22,"diseaseTypeName":"Skin Diseases"}],"organizations":[{"resourceID":194,"resourceName":"Scleroderma Foundation","abbreviation":"","address1":"300 Rosewood Drive, Suite 105","address2":"","address3":"","address4":"","address5":"","city":"Danvers","state":"MA","zip":"01923","country":"United States","phone":"+1-978-463-5843 ","tty":"","tollFree":"1-800-722-4673 (HOPE)","fax":"+1-978-463-5809","email":"sfinfo@scleroderma.org","url":"https://www.scleroderma.org","freeText":""},{"resourceID":359,"resourceName":"International Scleroderma Network (ISN)","abbreviation":"","address1":"7455 France Ave So #266","address2":"","address3":"","address4":"","address5":"","city":"Edina","state":"MN","zip":"55435-4702 ","country":"United States","phone":"+1-952-831-3091","tty":"","tollFree":"1-800-564-7099","fax":"","email":"isn@sclero.org","url":"https://www.sclero.org/index.html","freeText":""},{"resourceID":360,"resourceName":"Scleroderma Research Foundation","abbreviation":"","address1":"220 Montgomery Street, Suite 484","address2":"","address3":"","address4":"","address5":"","city":"San Francisco","state":"CA","zip":"94104 ","country":"United States","phone":"+1-415-834-9444 ","tty":"","tollFree":"","fax":"","email":"info@srfcure.org","url":"https://srfcure.org/","freeText":""}],"resource descriptions":[{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=DetailsSearch&Term=morphea%5Bti%5D+AND+%28%222008%2F04%2F03%22%5BPDat%5D+%3A+%222009%2F04%2F02%22%5BPDat%5D%29' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Morphea. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Morphea%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Morphea. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":803,"resourceId":1482,"resourceName":"Scleroderma Clinical Trials Consortium","descriptionText":"The <a href=\"http://sites.bu.edu/sctc/\"><a href='https://sites.bu.edu/sctc/' target='_blank'>Scleroderma Clinical Trials Consortium</a></a> is an international organization of scleroderma clinical researchers. The consortium Web site&nbsp;contains&nbsp;a listing of active scleroderma trials,&nbsp;past copies of the Scleroderma Care and Research&nbsp;journal, and&nbsp;a tool for finding your nearest member institution.&nbsp;","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":804,"resourceId":1482,"resourceName":"Scleroderma Clinical Trials Consortium","descriptionText":"Select volumes of the <a href='http://www.med.umich.edu/scleroderma/professionals/journal.htm' target='_blank'>Scleroderma Care and Research Journal</a><em> </em>can be viewed by visiting the Scleroderma Clinical Trials Consortium Web site. Click on the link above to learn more.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Selected Full-Text Journal Articles"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/69/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1529,"resourceId":2128,"resourceName":"MedlinePlus","descriptionText":"<a href='http://www.nlm.nih.gov/medlineplus/scleroderma.html' target='_blank'>MedlinePlus</a> was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic.\r\n<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://www.emedicine.com/derm/TOPIC272.HTM' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1550,"resourceId":2178,"resourceName":"DermNet New Zealand","descriptionText":"<a href='http://www.dermnetnz.org/immune/morphoea.html' target='_blank'>DermNet NZ</a> is an online resource about skin diseases developed by the New Zealand Dermatological Society Incorporated. DermNet NZ provides information about this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1562,"resourceId":2179,"resourceName":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","descriptionText":"The <a href='http://www.niams.nih.gov/Health_Info/Scleroderma/default.asp#2' target='_blank'>National Institute of Arthritis and Musculoskeletal and Skin Diseases</a> (NIAMS) support research into the causes, treatment, and prevention of arthritis and musculoskeletal and skin diseases, the training of basic and clinical scientists to carry out this research, and the dissemination of information on research progress in these diseases.  Click on the link to view information on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1591,"resourceId":2206,"resourceName":"Facebook Groups","descriptionText":"Visit the <a href='https://www.facebook.com/groups/8595570962/' target='_blank'>Morphea</a> group on Facebook.","resourceClassificationName":"Organizations","resourceClassificationSectionName":"Social Networking Websites"},{"id":1764,"resourceId":2924,"resourceName":"Mayo Clinic","descriptionText":"The <a href='http://www.mayoclinic.org/diseases-conditions/morphea/basics/definition/con-20028397' target='_blank'>Mayo Clinic</a> Web site provides further information on Morphea.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/DOID:8472' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2781,"resourceId":4265,"resourceName":"Autoimmune Registry","descriptionText":"The <a href='http://www.autoimmuneregistry.org/' target='_blank'>Autoimmune Registry</a> supports research for Morphea by collecting information about patients with this and other autoimmune diseases. You can join the registry to share your information with researchers and receive updates about participating in new research studies.&nbsp;<a href=\"https://www.nih.gov/health-information/nih-clinical-research-trials-you/list-registries\" target=\"_blank\">Learn more about registries.</a>","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"}],"overviewQuestion":{"questionId":1966,"questionText":"What is morphea?","answerText":"<strong>Morphea</strong>&nbsp;is a skin condition that causes patches of  reddish skin that thicken into firm, oval-shaped areas. It is a form of&nbsp;<a href=\"https://rarediseases.info.nih.gov/diseases/10308/scleroderma\" tabindex=\"-1\" target=\"_blank\">scleroderma</a>.&nbsp;Patches most often occur on the abdomen, stomach, and back, and sometimes on the face, arms and legs.[12342][12343] Morphea is classified according to the localization of the lesions and the depth of tissue involvement into localized or circumscribed&nbsp;(limited to one or several patches) , generalized&nbsp;(spread over larger areas of the body), linear (with linear lesions involving the outer skin and deeper layers), and pansclerotic (that involves not just the outer skin but the deeper layers, and sometimes the bone underneath, and also restricts movement of the joints).[12343][7118][12360] The underlying cause of morphea is unknown. It may be associated with an abnormal immune response, or be triggered by radiation therapy, repeated trauma to the affected area, or a recent infection.[12343]&nbsp;It usually goes away without treatment within 3 to 5 years, but some people are left with darkened areas of skin or rarely muscle weakness.[12342] Treatment may be used to control symptoms until it resolves, and may include <a href=\"http://www.dermnetnz.org/topics/phototherapy/\" target=\"_blank\">phototherapy</a>, prescription vitamin D creams, or <a href=\"http://www.nlm.nih.gov/medlineplus/steroids.html\" target=\"_blank\">corticosteroids</a>.[12343]","dateModified":"2018-02-15T00:00:00"},"basicQuestions":[{"questionId":768,"questionText":"What are the signs and symptoms of morphea?","answerText":"The signs and symptoms of morphea can vary depending on the type and severity. Morphea usually causes reddish patches of skin that thicken (sclerosis) into firm, oval-shaped areas. The center of each patch may develop a lighter center.[12343] These patches sweat less than unaffected areas and may lose hair over time. Patches most often occur on the chest, stomach, and back, and sometimes occur on the face, arms, and legs.[12342][12343]&nbsp;<span style=\"font-size: 12pt;\">According to the localization and deepness of the lesions morphea may be classified in:[12342][12343][12360]</span>\r\n<ul>\r\n    <li>Localized or circumscribed which is limited to one or several patches on the trunk, legs and arms&nbsp;</li>\r\n    <li>Generalized, spread over larger areas of the body, in the trunk, legs and limbs&nbsp;</li>\r\n    <li>Linear,&nbsp;&nbsp;where there are linear bands of thick skin that involve the deeper layers of the skin and are localized in the legs, arms, upper body or head</li>\r\n    <li>Morphea profunda or pansclerotic, which involves also the tissue below the skin and may restrict the joint movement.</li>\r\n</ul>","dateModified":"2018-02-15T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":12342,"authors":"","articleTitle":"Handout on Health: Scleroderma","bookWebsiteJournalTitle":"NIAMS","date":"February, 2015","volume":"","pages":"","url":"http://www.niams.nih.gov/Health_Info/Scleroderma/default.asp#2","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":12343,"authors":"","articleTitle":"Morphea","bookWebsiteJournalTitle":"Mayo Clinic","date":"September 29, 2015","volume":"","pages":"","url":"http://www.mayoclinic.org/diseases-conditions/morphea/basics/definition/con-20028397","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":12360,"authors":"Heidi Jacobe","articleTitle":"Pathogenesis, clinical manifestations, and diagnosis of morphea (localized scleroderma) in adults","bookWebsiteJournalTitle":"UpToDate","date":"September, 2016","volume":"","pages":"","url":"","authors2":"","placeOfPublication":"Waltham, MA","publisher":"UpToDate"}]},{"questionId":767,"questionText":"What causes morphea?","answerText":"The underlying cause of morphea is poorly understood. Theories on the cause are often drawn from studies of <a href=\"https://rarediseases.info.nih.gov/diseases/9748/systemic-sclerosis\" target=\"_blank\">systemic sclerosis</a>. A variety of factors, including <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000816.htm\" target=\"_blank\">autoimmunity</a>, genetics, and vascular dysfunction may play a role in morphea. Multiple environmental factors (such as radiation, infections, skin trauma, or environmental exposures) also have been proposed as contributors to the development of morphea.[12360]","dateModified":"2018-02-15T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":12360,"authors":"Heidi Jacobe","articleTitle":"Pathogenesis, clinical manifestations, and diagnosis of morphea (localized scleroderma) in adults","bookWebsiteJournalTitle":"UpToDate","date":"September, 2016","volume":"","pages":"","url":"","authors2":"","placeOfPublication":"Waltham, MA","publisher":"UpToDate"}]},{"questionId":769,"questionText":"How might morphea be treated?","answerText":"Treatment for morphea is aimed at&nbsp;controlling the symptoms and depends on the severity  and body surface area involved. In general, active disease (present &lt;3 months or with symptoms of inflammation) is most responsive to treatment.&nbsp;Because morphea typically goes away on its own eventually, treating the condition is optional for  uncomplicated, localized cases.<br />\r\n<br />\r\nThe majority of adults with morphea are managed with observation, topical medications, or <a href=\"http://www.dermnetnz.org/topics/phototherapy/\" target=\"_blank\">phototherapy</a>.&nbsp;Aggressive, <a href=\"https://www.cancer.gov/publications/dictionaries/cancer-terms?cdrid=45922\" target=\"_blank\">systemic therapy</a>&nbsp;with <a href=\"https://medlineplus.gov/druginfo/meds/a682019.html\" target=\"_blank\">methotrexate</a>&nbsp;and/or <a href=\"https://medlineplus.gov/steroids.html\" target=\"_blank\">glucocorticoids</a>&nbsp;is needed for those with active, deep morphea; lesions that may cause significant cosmetic disfigurement; joint contractures; or other functional impairment. Occupational and physical therapy are also important for those at risks for physical limitations. Phototherapy is also preferred for those with generalized morphea, but it is not an option for those with deep morphea due to the poor ability of ultraviolet light to penetrate deep tissues.[9999]<br />\r\n<br />\r\n<a href=\"http://emedicine.medscape.com/article/1065782-treatment\" target=\"_blank\">Detailed information about how morphea might be treated can be viewed here on Medscape Reference's website</a>.","dateModified":"2018-02-15T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":9999,"authors":"Heidi Jacobe","articleTitle":"Treatment of morphea (localized scleroderma) in adults","bookWebsiteJournalTitle":"UpToDate","date":"September, 2016","volume":"","pages":"","url":"","authors2":"","placeOfPublication":"Waltham, MA","publisher":"UpToDate"}]},{"questionId":770,"questionText":"What is the long-term outlook for people with morphea?","answerText":"Morphea usually has a benign, self-limited course and life expectancy is typically normal. When lesions are superficial and circumscribed, the skin condition tends to slowly go away with time, with each individual lesion lasting an average of 3-5 years. However, some patients develop new lesions over their lifetimes.[12106] Even after morphea resolves,&nbsp;changes in skin color&nbsp;may last for years.[12363]<br />\r\n<br />\r\nLinear morphea usually lasts longer, but also eventually improves.[12363] Linear and deep (panslerotic) morphea may cause considerable morbidity, especially in children, interfering with growth. Joint contractures, limb-length discrepancy, and prominent facial atrophy (shrinkage of underlying tissues) can cause substantial disability and deformity in people with linear or deep morphea.[12106]&nbsp;Limbs affected by severe morphea may be stiff and weak if there is muscle wasting.[12363]","dateModified":"2018-02-15T00:00:00","resourceClassificationName":"Prognosis","references":[{"referenceId":12106,"authors":"Nguyen JV","articleTitle":"Morphea","bookWebsiteJournalTitle":"Medscape Reference","date":"2017","volume":"","pages":"","url":"http://emedicine.medscape.com/article/1065782","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":12363,"authors":"Oakley A","articleTitle":"Morphea","bookWebsiteJournalTitle":"DermNet NZ","date":"1999","volume":"","pages":"","url":"http://www.dermnetnz.org/topics/morphoea/","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[{"relatedDiseaseId":7058,"relatedDiseaseName":"Localized scleroderma","relation":"Parent","isRare":true,"hasGardPage":true}],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[],"medicalProducts":[],"EncodedName":"Morphea"}